Home  >  Products  >  VNN2 (vanin 2 ) Blocking Peptide (the C terminal of VNN2)(100ug)
VNN2 (vanin 2 ) Blocking Peptide (the C terminal of VNN2)(100ug)

VNN2 (vanin 2 ) Blocking Peptide (the C terminal of VNN2)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-VNN2 Antibody (ARP61815_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61815
Size: 100ug
Weight: 57kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene product is a member of the Vanin family of proteins that share extensive sequence similarity with each other, and also with biotinidase. The family includes secreted and membrane-associated proteins, a few of which have been reported to participate in hematopoietic cell trafficking. No biotinidase activity has been demonstrated for any of the vanin proteins, however, they possess pantetheinase activity, which may play a role in oxidative-stress response. The encoded protein is a GPI-anchored cell surface molecule that plays a role in transendothelial migration of neutrophils. This gene lies in close proximity to, and in same transcriptional orientation as two other vanin genes on chromosome 6q23-q24. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.
Alternative names: FOAP-4; GPI-80